quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:30:00·1976d
PRRelease
Lantern Pharma Inc. logo
VolitionRX Limited logo
Comtech Telecommunications Corp. logo
+4

Diamond Equity Research 2020 Virtual Emerging Growth Invitational

LTRN· Lantern Pharma Inc.VNRX· VolitionRX LimitedCMTL· Comtech Telecommunications Corp.GNPX· Genprex Inc.LPTH· LightPath Technologies Inc.HHT· Color Star Technology Co. Ltd.
Health CareTechnologyBasic Industries
Original source

Companies

  • LTRN
    Lantern Pharma Inc.
    Health Care
  • VNRX
    VolitionRX Limited
    Health Care
  • CMTL
    Comtech Telecommunications Corp.
    Technology
  • GNPX
    Genprex Inc.
    Health Care
  • LPTH
    LightPath Technologies Inc.
    Technology
  • HHT
    Color Star Technology Co. Ltd.
    Basic Industries
  • MEDS
    TRxADE HEALTH Inc.
    Health Care

Recent analyst ratings

  • Jan 29LPTHUpdateCanaccord Genuity$15.00
  • Apr 28LPTHUpdateCraig Hallum$5.50
  • Apr 8VNRXUpdateH.C. Wainwright$2.50
  • Jan 3LPTHUpdateH.C. Wainwright$5.00
  • Jun 25CMTLUpdateJefferies$3.50
  • Dec 15CMTLUpdateB. Riley Securities$18.25

Related

  • SEC19h
    VolitionRX Limited filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits
  • PR19h
    VolitionRx Announces Acceptance of Compliance Plan by NYSE American
  • PR1d
    Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual Meeting
  • SEC2d
    Genprex Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
  • PR2d
    Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy
  • PR3d
    Emerging Data for Lantern Pharma's Investigational Drug LP-300 Demonstrates 8.3-Month Median Progression-Free Survival in Patients with EGFR L858R Lung Cancer After Targeted Therapy Failure — With No Added Toxicity
  • PR3d
    Volition Launches rNuQ™ Webshop Broadening Product Range
  • PR3d
    Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022